Table 2 Influence of streptococcal infection to the therapeutic response of HSP
Streptococcal infection (n = 393) | The other infections (n = 637) | Non-infection (n = 1044) | |||||||
|---|---|---|---|---|---|---|---|---|---|
Total cases | Relieved cases (%) | Duration time (day) | Total cases | Relieved cases (%) | Duration time (day) | Total cases | Relieved cases (%) | Duration time (day) | |
Clinical manifestations | |||||||||
Purpura | 393 | 303 (77.1%) | 5.9 ± 4.0 | 637 | 525 (82.4%) | 5.6 ± 3.8 | 1044 | 726 (69.5%) | 5.0 ± 3.7 |
Arthritis/arthralgia | 169 | 169 (100%) | 2.5 ± 1.9 | 293 | 293 (100%) | 2.7 ± 2.2 | 334 | 332 (99.4%) | 2.5 ± 1.6 |
Abdominal pain | 126 | 126 (100%) | 2.7 ± 2.4 | 246 | 246 (100%) | 3.2 ± 2.7 | 357 | 353 (98.9%) | 2.8 ± 2.8 |
Renal involvement | 115 | 56 (48.7%) | 6.4 ± 4.8 | 149 | 83 (55.7%) | 7.2 ± 5.8 | 357 | 154 (43.1%) | 5.0 ± 4.9 |
Total cases | Frequency (times) | Total cases | Frequency (times) | Total cases | Frequency (times) | ||||
Relapse/recurrence | 76 | 1.9 ± 1.8 | 130 | 1.6 ± 1.4 | 335 | 2.6 ± 2.0 | |||